9 3 7159 (Pergolide 0.25 mg)
Pill imprint 9 3 7159 has been identified as Pergolide mesylate 0.25 mg.
Pergolide is used in the treatment of parkinson's disease; tourette's syndrome; hyperprolactinemia and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Pergolide 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 9 3 7159
- Strength:
- 0.25 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
More about pergolide
Consumer resources
- Other brands: Permax
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
